Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study

Blood (2024) 144 (Supplement 1): 773.

https://doi.org/10.1182/blood-2024-201057

Published: 2024

Journal Articles

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry

Blood (2019) 134 (Supplement_1): 4161.

https://doi.org/10.1182/blood-2019-127923

Published: 2019

Journal Articles

Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry

Timothy Devos, Koen Theunissen, Fleur Samantha Benghiat, Alain Gadisseur, Stef Meers, Dominik Selleslag, Gaëtan Vanstraelen, Pierre Zachée, Marc André, Philippe Lewalle, MD, Mia Janssen, Rik Schots, Koen Van Eygen, Alain Kentos, Marie Lejeune, Agnes Triffet, Inge Vrelust, Carolina Kuipers, Violaine Havelange

Blood (2018) 132 (Supplement 1): 1744.

https://doi.org/10.1182/blood-2018-99-114070

Published: 2018

Journal Articles

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Yves Beguin, MD PhD, Pierre Zachee, MD PhD, Johan Maertens, MD PhD, Tessa Kerre, MD PhD, Aurelie Ory, Laurence Seidel, Carlos Graux, MD PhD, Philippe Lewalle, MD PhD, Michel Van Gelder, PhD MD, Koen Theunissen, Evelyne Willems, MD PhD, Marie-Paule Emonds, Ann De Becker, Frederic Baron

Blood (2014) 124 (21): 542.

https://doi.org/10.1182/blood.V124.21.542.542

Published: 2014

Journal Articles

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Mary Frances McMullin, MD, Claire N Harrison, DM FRCP FRCPath, Dietger Niederwieser, Hilde Demuynck, Nadja Jakel, Andres Sirulnik, MD, PhD, Mari McQuity, RN, MPH, Viktoriya Stalbovskaya, PhD, Christian Recher, MD, Koen Theunissen, MD, Heinz Gisslinger, MD, Jean-Jacques Kiladjian, MD, PhD, Haifa-Kathrin Al- Ali

Blood (2012) 120 (21): 2838.

https://doi.org/10.1182/blood.V120.21.2838.2838

Published: 2012

Journal Articles

Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial

Yves Beguin, Johan Maertens, Bernard De Prijck, Rik Schots, MD, Pascale Frere, Christophe Bonnet, Kaoutar Hafraoui, Evelyne Willems, Gaetan Vanstraelen, Marie Lejeune, Koen Theunissen, Georges Fillet, Frederic Baron

Blood (2008) 112 (11): 54.

https://doi.org/10.1182/blood.V112.11.54.54

Published: 2008

Journal Articles

PAD Is a Highly Effective Regimen for the Treatment of Patients with Relapsed Refractory Multiple Myeloma.

Michel Delforge, MD, PhD, Ann Janssens, MD, Daan Dierickx, MD, Johan Maertens, MD, Koen Theunissen, MD, Peter Vandenberghe, MD,PhD, Gregor Verhoef, MD,PhD

Blood (2006) 108 (11): 5095.

https://doi.org/10.1182/blood.V108.11.5095.5095

Published: 2006

Journal Articles

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Blood (2006) 108 (9): 2928–2936.

https://doi.org/10.1182/blood-2006-03-008706

Published: 2006

Journal Articles

Natural History of Post-Allogeneic HSCT EBV-Reactivation: A Single Center Retrospective Survey.

Helene M. Schoemans, MD, Koen Theunissen, MD, Marc Boogaerts, MD, PhD, Johan Maertens, MD

Blood (2005) 106 (11): 3232.

https://doi.org/10.1182/blood.V106.11.3232.3232

Published: 2005

Journal Articles

Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization.

Marc Tjwa, MD, PhD, Lieve Moons, PhD, Koen Theunissen, MD, Rute Moura, MSc, PhD, Francesco Blasi, MD, PhD, Mieke Dewerchin, PhD, Nicolai Sidenius, PhD, Desire Collen, MD, PhD, Peter Carmeliet, MD, PhD

Blood (2005) 106 (11): 472.

https://doi.org/10.1182/blood.V106.11.472.472

Published: 2005

Journal Articles

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Dominique Bron, MD, PhD, Pierre Zachée, MD, Johan Maertens, MD, Koen Theunissen, MD, Augustin Ferrant, MD, PhD, Philippe Martiat, MD, PhD, Chantal Doyen, MD, Luc Noens, MD, Wilfried Schroyens, MD, Dominique Sellesslag, MD, Hilde Demuynck, MD, Rick Schots, MD, PhD, Anne De Meuter, Marc Boogaerts, MD, PhD

Blood (2004) 104 (11): 5046.

https://doi.org/10.1182/blood.V104.11.5046.5046

Published: 2004

Journal Articles

Novel Role of Plasmin in Mobilization and of uPAR in Retention of Hematopoietic Stem/Progenitor Cells in the Bone Marrow Niche: Therapeutic Implications.

Marc Tjwa, MD, Nicolai Sidenius, PhD, Koen Theunissen, MD, Rute Moura, MSc, Lieve Moons, PhD, Stefan Janssens, MD, PhD, Francesco Blasi, MD, Desire Collen, MD, PhD, Peter Carmeliet, MD, PhD

Blood (2004) 104 (11): 117.

https://doi.org/10.1182/blood.V104.11.117.117

Published: 2004

Journal Articles

Targeted Pre-Emptive Anti- Aspergillus Therapy in Neutropenic Patients Not Receiving Empirical Antifungal Therapy.

Johan A. Maertens, MD, Koen Theunissen, MD, Gregor Verhoef, MD, Johnny Verschaekelen, MD, PhD, Katrien Lagrou, MD, PhD, Eric Verbeken, MD, PhD, Jan Verhaegen, MD, PhD, Wouter Meersseman, MD, Alexander Wilmer, MD, PhD, Marc Boogaerts, MD, PhD, Johan Van Eldere, MD, PhD

Blood (2004) 104 (11): 2231.

https://doi.org/10.1182/blood.V104.11.2231.2231

Published: 2004

Journal Articles

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Philippe Lewalle, MD, Alain Delforge, PhD, Berengere Nowak, BS, Virginie Misplon, Laurence Lagneaux, PhD, Koen Theunissen, MD, PhD, Jalil Bennani, MD, Dominique Bron, MD, PhD, Philippe Martiat, MD, PhD

Blood (2004) 104 (11): 4975.

https://doi.org/10.1182/blood.V104.11.4975.4975

Published: 2004

NARROW

Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry

Efficacy and Safety of Ponatinib in CML and Ph+ ALL Patients in Real-World Clinical Practice: Data from a Belgian Registry

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial

PAD Is a Highly Effective Regimen for the Treatment of Patients with Relapsed Refractory Multiple Myeloma.

Natural History of Post-Allogeneic HSCT EBV-Reactivation: A Single Center Retrospective Survey.

Role of Plasmin and uPAR in Bone Marrow HSC/HPC Retention and Mobilization.

Fludarabine Phosphate-Based Nonmyeloablative Stem Cell Transplantation in the Elderly Patients: A BHS Study.

Novel Role of Plasmin in Mobilization and of uPAR in Retention of Hematopoietic Stem/Progenitor Cells in the Bone Marrow Niche: Therapeutic Implications.

Targeted Pre-Emptive Anti- Aspergillus Therapy in Neutropenic Patients Not Receiving Empirical Antifungal Therapy.

Can Addition of GM-CSF in Adult Haplo-Identical Transplant Who Cannot Benefit from NK Alloreactivity Improve the Relapse Rate of Advanced Leukemia: A 3 Step Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only